药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Zopiclone
Clorexolone
Clorexolone may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.
Zopiclone
Cyclopenthiazide
Cyclopenthiazide may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.
Zopiclone
Mebutizide
Mebutizide may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.
Zopiclone
Mefruside
Mefruside may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.
Zopiclone
Meticrane
Meticrane may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.
Zopiclone
Cicletanine
Cicletanine may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.
Zopiclone
Spiradoline
Spiradoline may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.
Zopiclone
Rolofylline
Rolofylline may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.
Zopiclone
Canrenone
Canrenone may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.
Zopiclone
Efonidipine
Efonidipine may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.
Zopiclone
Canrenoic acid
Canrenoic acid may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.
Zopiclone
Azosemide
Azosemide may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.
Zopiclone
Indisulam
Indisulam may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.
Zopiclone
Ularitide
Ularitide may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.
Zopiclone
Tienilic acid
Tienilic acid may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.
Zopiclone
Piretanide
Piretanide may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.
Zopiclone
Theobromine
Theobromine may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.
Zopiclone
Quinethazone
Quinethazone may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.
Zopiclone
Mersalyl
Dabigatran etexilate may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy.
Zopiclone
Lithium carbonate
Dabigatran etexilate may decrease the excretion rate of Lithium carbonate which could result in a higher serum level.